Magnetic resonance spectroscopy in MELAS syndrome: correlation with CSF and plasma metabolite levels and change after glutamine supplementation.
María Paz Guerrero-MolinaÁngela Bernabeu-SanzAna Ramos-GonzálezMontserrat Morales-ConejoAitor DelmiroCristina Domínguez-GonzálezJoaquín ArenasMiguel Angel MartinJesús González de la AlejaPublished in: Neuroradiology (2023)
ClinicalTrials.gov Identifier: NCT04948138; initial release 24/06/2021; first patient enrolled on 1/07/2021. https://clinicaltrials.gov/ct2/show/NCT04948138.